Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Gemcitabine 83 Cisplatin 59 pembrolizumab 28 Paclitaxel 21 Nivolumab 21 Carboplatin 21 Cystectomy 20 Docetaxel 18 durvalumab 17 atezolizumab 17 Magnetic Resonance Spectroscopy 16 Specimen Handling 15 Radiotherapy 14 avelumab 13 Mitomycin 13 Sunitinib 12 Doxorubicin 12 Methotrexate 11 Fluorouracil 11 Vinblastine 10 Filgrastim 7 BCG Vaccine 7 Sorafenib 6 Ipilimumab 6 Immunoglobulin G 6 Disulfides 6 Biopsy 6 enfortumab vedotin 5 cabozantinib 5 Trastuzumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Urinary Bladder Neoplasms × Radiotherapy, Adjuvant × Clear all

NCT05445648 2022-12-28

CBPTMI

First Affiliated Hospital Xi'an Jiaotong University

Phase 2 Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡